109 related articles for article (PubMed ID: 11834448)
1. Effects of glucagon-like peptide-1(7-36) amide on neurohypophysial and cardiovascular functions under hypo- or normotensive hypovolaemia in the rat.
Bojanowska E; Stempniak B
J Endocrinol; 2002 Feb; 172(2):303-10. PubMed ID: 11834448
[TBL] [Abstract][Full Text] [Related]
2. Effects of tGLP-1 on feeding behaviour and neurohypophysial function under chronic osmotic stimulation.
Bojanowska E; Stempniak B
Physiol Behav; 2003 Jan; 78(1):73-9. PubMed ID: 12536013
[TBL] [Abstract][Full Text] [Related]
3. tGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effects of a tGLP-1 receptor agonist and antagonist.
Bojanowska E; Stempniak B
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):781-93. PubMed ID: 11785773
[TBL] [Abstract][Full Text] [Related]
4. Effects of glucagon-like peptide-1 (7-36) amide on neurohypophysial hormone secretion induced by acute hyperosmotic challenge.
Bojanowska E; Stempniak B
Neuropeptides; 2003 Feb; 37(1):45-50. PubMed ID: 12637035
[TBL] [Abstract][Full Text] [Related]
5. Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat.
Bojanowska E; Stempniak B
Regul Pept; 2000 Jul; 91(1-3):75-81. PubMed ID: 10967203
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in glucagon-like peptide-1 (7-36) amide action on the rat hypothalamo-neurohypophysial system.
Bojanowska E; Stempniak B
Neuroendocrinology; 2003 Feb; 77(2):119-24. PubMed ID: 12624533
[TBL] [Abstract][Full Text] [Related]
7. tGLP-1 action on the isolated hypothalamo-neurohypophysial system under glutamate receptor blockade.
Bojanowska E; Stempniak B
Brain Res Bull; 2002 Sep; 58(6):555-9. PubMed ID: 12372558
[TBL] [Abstract][Full Text] [Related]
8. Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats.
Barragán JM; Eng J; Rodríguez R; Blázquez E
Am J Physiol; 1999 Nov; 277(5):E784-91. PubMed ID: 10567003
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic factor inhibits the stimulated in-vivo and in-vitro release of vasopressin and oxytocin in the rat.
Poole CJ; Carter DA; Vallejo M; Lightman SL
J Endocrinol; 1987 Jan; 112(1):97-102. PubMed ID: 2950195
[TBL] [Abstract][Full Text] [Related]
10. Galanin affects vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in haemorrahaged rats.
Ciosek J; Cisowska A; Dabrowski R
J Physiol Pharmacol; 2003 Jun; 54(2):233-46. PubMed ID: 12832724
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.
Crespel A; De Boisvilliers F; Gros L; Kervran A
Endocrinology; 1996 Sep; 137(9):3674-80. PubMed ID: 8756532
[TBL] [Abstract][Full Text] [Related]
12. Glycation of glucagon-like peptide-1(7-36)amide: characterization and impaired action on rat insulin secreting cells.
O'Harte FP; Abdel-Wahab YH; Conlon JM; Flatt PR
Diabetologia; 1998 Oct; 41(10):1187-93. PubMed ID: 9794106
[TBL] [Abstract][Full Text] [Related]
13. N-terminally modified glucagon-like peptide-1(7-36) amide exhibits resistance to enzymatic degradation while maintaining its antihyperglycaemic activity in vivo.
O'Harte FP; Mooney MH; Lawlor A; Flatt PR
Biochim Biophys Acta; 2000 Mar; 1474(1):13-22. PubMed ID: 10699485
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of glucagon-like peptide-1 (GLP-1) receptor, vasopressin, and oxytocin mRNAs in neurons of the rat hypothalamic supraoptic and paraventricular nuclei: effect of GLP-1(7-36)amide on vasopressin and oxytocin release.
Zueco JA; Esquifino AI; Chowen JA; Alvarez E; Castrillón PO; Blázquez E
J Neurochem; 1999 Jan; 72(1):10-6. PubMed ID: 9886049
[TBL] [Abstract][Full Text] [Related]
15. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
16. Differential Role of Neurohypophysial Hormones in Hypotension and Nitric Oxide Production During Endotoxaemia.
Stabile AM; Moreto V; Batalhão ME; Rocha MJ; Antunes-Rodrigues J; Cárnio EC
J Neuroendocrinol; 2016 Jun; 28(6):. PubMed ID: 27037598
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats.
Ciosek J
J Physiol Pharmacol; 2002 Sep; 53(3):423-37. PubMed ID: 12369739
[TBL] [Abstract][Full Text] [Related]
18. The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor.
Nishizawa M; Nakabayashi H; Kawai K; Ito T; Kawakami S; Nakagawa A; Niijima A; Uchida K
J Auton Nerv Syst; 2000 Apr; 80(1-2):14-21. PubMed ID: 10742535
[TBL] [Abstract][Full Text] [Related]
19. Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.
Lundin S; Melin P; Vilhardt H
Experientia; 1985 Jul; 41(7):933-5. PubMed ID: 4007132
[TBL] [Abstract][Full Text] [Related]
20. The effect of neosurugatoxin on the release of neurohypophysial hormones by nicotine, hypotension and an osmotic stimulus in the rat.
Bisset GW; Fairhall KM; Tsuji K
Br J Pharmacol; 1992 Jul; 106(3):685-92. PubMed ID: 1504751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
